Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Waguespack

Showing results (131-140 of 177) with videos related to

Pageof 18
Sort By:
The Lancet. Diabetes & Endocrinology|June 16, 2025
Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysisKatherine A English, Carolina R C Pieterman, Francesca Marini, et al.
Endocrine|July 25, 2015
Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosisLevent Ozsari, Merve Kutahyalioglu, Khaled M Elsayes, et al.
Head & Neck|October 19, 2017
Management of the lateral neck compartment in patients with sporadic medullary thyroid cancerIsrael Pena, Gary L Clayman, Elizabeth G Grubbs, et al.
The Lancet. Oncology|September 22, 2018
Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trialEric Jonasch, Ian E McCutcheon, Dan S Gombos, et al.
Endocrine-Related Cancer|April 23, 2021
Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patternsHa Nguyen, Komal Shah, Steven G Waguespack, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2025
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practiceMaria Luisa Brandi, Carolina R C Pieterman, Katherine A English, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignanciesDavid S Hong, Maria E Cabanillas, Jennifer Wheler, et al.
Thyroid : Official Journal of the American Thyroid Association|September 28, 2016
Medullary Thyroid Carcinoma Associated with Germline RET<sup>K666N</sup> MutationJian Yu Xu, Elizabeth G Grubbs, Steven G Waguespack, et al.
Journal of the Endocrine Society|April 25, 2024
Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease AggressivenessAditya S Shirali, Mimi I Hu, Yi-Ju Chiang, et al.
Thyroid : Official Journal of the American Thyroid Association|August 25, 2018
Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth EditionsSamantha Tam, Mongkol Boonsripitayanon, Moran Amit, et al.
Pageof 18

Showing results (131-140 of 177) with videos related to

Sort By:
Pageof 18
The Lancet. Diabetes & Endocrinology|June 16, 2025
Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysisKatherine A English, Carolina R C Pieterman, Francesca Marini, et al.
Endocrine|July 25, 2015
Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosisLevent Ozsari, Merve Kutahyalioglu, Khaled M Elsayes, et al.
Head & Neck|October 19, 2017
Management of the lateral neck compartment in patients with sporadic medullary thyroid cancerIsrael Pena, Gary L Clayman, Elizabeth G Grubbs, et al.
The Lancet. Oncology|September 22, 2018
Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trialEric Jonasch, Ian E McCutcheon, Dan S Gombos, et al.
Endocrine-Related Cancer|April 23, 2021
Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patternsHa Nguyen, Komal Shah, Steven G Waguespack, et al.
The Lancet. Diabetes & Endocrinology|June 16, 2025
Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practiceMaria Luisa Brandi, Carolina R C Pieterman, Katherine A English, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2011
Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignanciesDavid S Hong, Maria E Cabanillas, Jennifer Wheler, et al.
Thyroid : Official Journal of the American Thyroid Association|September 28, 2016
Medullary Thyroid Carcinoma Associated with Germline RET<sup>K666N</sup> MutationJian Yu Xu, Elizabeth G Grubbs, Steven G Waguespack, et al.
Journal of the Endocrine Society|April 25, 2024
Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease AggressivenessAditya S Shirali, Mimi I Hu, Yi-Ju Chiang, et al.
Thyroid : Official Journal of the American Thyroid Association|August 25, 2018
Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth EditionsSamantha Tam, Mongkol Boonsripitayanon, Moran Amit, et al.
Pageof 18